Transplantation of fetal-derived cells for neurological disorders
- Authors: Seiedtsova G.V.1, Seledtsov V.I.1, Rabinovich S.S.2, Parluk O.V.3, Kafanova M.Y.4
-
Affiliations:
- Institute of clinical immunology SB RAMS
- Institute of travmatology and orthopedy
- City clinical hospital № 34
- Children’s clinical hospital № 1
- Issue: Vol 3, No 1 (2008)
- Pages: 49-56
- Section: Original Study Articles
- URL: https://genescells.ru/2313-1829/article/view/317436
- ID: 317436
Cite item
Open Access
Access granted
Abstract
Both literature and our own data addressed to transplanting fetal-derived cells for neurologic disorders are reviewed in this paper. According these data, the transplantation of the cells derived from nervous and hemopoietic tissues may be an effective treatment for consequences of craniocerebral trauma, cerebral stroke, spinal cord injury, neuroinfection and of cerebral palsy. The predominant role in the formation of therapeutic effects is assumed to belong to neurotrophic factors being released by grafted cells in the brain injury lessions.
Keywords
Full Text
About the authors
G. V. Seiedtsova
Institute of clinical immunology SB RAMS
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Novosibirsk
V. I. Seledtsov
Institute of clinical immunology SB RAMS
Email: info@eco-vector.com
Russian Federation, Novosibirsk
S. S. Rabinovich
Institute of travmatology and orthopedy
Email: info@eco-vector.com
Russian Federation, Novosibirsk
O. V. Parluk
City clinical hospital № 34
Email: info@eco-vector.com
Russian Federation, Novosibirsk
M. Yu. Kafanova
Children’s clinical hospital № 1
Email: info@eco-vector.com
Russian Federation, Novosibirsk
References
